Stage FocusPre-Seed, Seed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Longwood Fund manages $650M+ in total AUM, with Fund VI closing at $180M as their largest fund to date. The track record is exceptional for biotech company creation: partners have co-founded approximately 25 companies with 20+ launched and marketed drugs and therapies. Portfolio companies include GRAIL, BridgeBio, and PTC Therapeutics, alongside clinical-stage assets, with 10 IPOs and 8 acquisitio...
Notable Investments
G
GRAILB
BridgeBioP
PTC TherapeuticsA
AcceleronA
AlnylamV
VertexSimilar Funds
Boehringer Ingelheim Venture Fund
Ingelheim am Rhein, Germany
GeneralistBiotechMedTechPre-SeedSeed
Pacific Channel
Auckland, New Zealand
Pure DeepTechBiotechAgriTechClimate TechPre-SeedSeed
Amino Collective
Berlin, Germany
DeepTech NativeBiotechSynthetic BiologyMedTechPre-SeedSeed
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedTechSynthetic BiologySeedSeries A
Atlas Venture
Cambridge, United States
Pure DeepTechBiotechSynthetic BiologyMedTechSeedSeries A
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAI InfrastructureMedTechSeedSeries A